Zobrazeno 1 - 10
of 13
pro vyhledávání: '"L L, Mulloy"'
Publikováno v:
Journal of the Medical Association of Georgia. 87(2)
Living renal donation is an effective means to expand the organ donor pool and allow more transplants to be performed at greater convenience for the recipient and with greater long-term success. Risks to the recipient appear to be minimal as long as
Publikováno v:
Clinical transplantation. 15(5)
Non-compliance with immunosuppressive medications may result in allograft rejection and is regarded as an important impediment to post-transplant care. This randomized, controlled trial evaluates the impact of clinical pharmacy services on renal tran
Autor:
M A, Chisholm, L J, Vollenweider, L L, Mulloy, M, Jagadeesan, J J, Wynn, H E, Rogers, W E, Wade, J T, DiPiro
Publikováno v:
Transplantation. 70(8)
Noncompliance with immunosuppressive medications after renal transplantation is believed to be a major cause of allograft rejection and graft loss, with the impressive costs of these agents considered a significant reason for noncompliance. Our purpo
Publikováno v:
Clinical transplantation. 14(4 Pt 1)
Medicare pays for 80% of the cost of immunosuppressant agents needed within the first 3 years of solid organ transplantation; however, many patients cannot afford the remaining 20%. Furthermore, many patients who are beyond 3 years post-transplantati
Publikováno v:
Transplantation. 68(9)
Basiliximab is an interleukin-2 receptor (CD25) chimeric monoclonal antibody used for acute rejection prophylaxis in renal transplants. In the context of a randomized, double-blind efficacy trial, its population pharmacokinetics and potential exposur
Autor:
A O, Gaber, M R, First, R J, Tesi, R S, Gaston, R, Mendez, L L, Mulloy, J A, Light, L W, Gaber, E, Squiers, R J, Taylor, J F, Neylan, R W, Steiner, S, Knechtle, D J, Norman, F, Shihab, G, Basadonna, D C, Brennan, E E, Hodge, B D, Kahan, L, Kahan, S, Steinberg, E S, Woodle, L, Chan, J M, Ham, T J, Schroeder
Publikováno v:
Transplantation. 66(1)
Thymoglobulin, a rabbit anti-human thymocyte globulin, was compared with Atgam, a horse anti-human thymocyte globulin for the treatment of acute rejection after renal transplantation.A multicenter, double-blind, randomized trial with enrollment strat
Publikováno v:
Clinical transplantation. 11(5 Pt 2)
The impact of obesity on graft survival after renal transplantation continues to be controversial. We have reviewed our experiences with living donor and cadaver transplantation in the current decade, focusing specifically on the impact of obesity on
Publikováno v:
Southern medical journal. 84(5)
A review of hospital epidemiologic data disclosed five cases of polymicrobial bacteremia on a nephrology inpatient service over a period of 30 months. All five cases occurred in patients receiving long-term hemodialysis; four of them had indwelling s
Publikováno v:
Transplantation. 65:S190
Autor:
Ahsan N; Milton S. Hershey Medical Center, Hershey, PA 17104-1696, USA., Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE
Publikováno v:
Transplantation [Transplantation] 2001 Jul 27; Vol. 72 (2), pp. 245-50.